Leverandør: Sanofi-aventis Norge AS
4 arkiverte anskaffelser
Sanofi-aventis Norge AS har historisk levert medisinsk utstyr, legemidler og utstyr til personlig pleie, farmasøytiske produkter og antiinfektive midler for systemisk bruk, vaksiner, cytostatika/cytotoxiske midler, samt immunmodulerende midler.
Historisk har konkurrerende tilbydere vært Viatris AS og Mylan Healthcare Norge AS.
Nyeste anskaffelser der leverandøren Sanofi-aventis Norge AS nevnes
2022-09-19
Four valent vaccination against seasonal influenza (Folkehelseinstituttet)
Folkehelseinstituttet [the Norwegian Institute of Public Health] is holding an open tender contest with the aim of ensuring sufficient delivery of four valent vaccine against seasonal influenza (ATC code J07B B02) for vaccination of persons in defined risk and target groups (see the tender documentation point 1.4) for the 2023/2024 and 2024/2025 seasons, with an option for a further two seasons. The contest is being held electronically in the CTM KGV and information given in the tender management tool, … Vis anskaffelsen »
Folkehelseinstituttet [the Norwegian Institute of Public Health] is holding an open tender contest with the aim of ensuring sufficient delivery of four valent vaccine against seasonal influenza (ATC code J07B B02) for vaccination of persons in defined risk and target groups (see the tender documentation point 1.4) for the 2023/2024 and 2024/2025 seasons, with an option for a further two seasons. The contest is being held electronically in the CTM KGV and information given in the tender management tool, … Vis anskaffelsen »
2021-11-11
Four valent vaccine against seasonal influenza - Supplementary volume for the season 2022/2023 (Folkehelseinstituttet)
Folkehelseinstituttet [the Norwegian Institute of Public Health] is holding an open tender contest with the aim of ensuring sufficient delivery of four valent vaccine against seasonal influenza (ATC code J07B B02) for vaccination of adults in defined risk groups for the seasons 2022/2023. Vis anskaffelsen »
Folkehelseinstituttet [the Norwegian Institute of Public Health] is holding an open tender contest with the aim of ensuring sufficient delivery of four valent vaccine against seasonal influenza (ATC code J07B B02) for vaccination of adults in defined risk groups for the seasons 2022/2023. Vis anskaffelsen »
2018-11-27
4 Valent Vaccination against Seasonal Influenza (Folkehelseinstituttet)
The Norwegian Institute of Public Health is holding an open tender contest with the aim of ensuring sufficient deliveries of 4 valent vaccinations against seasonal influenza (ATC code J07B B02) for vaccinating adults in defined risk groups, (see the tender documentation, point 1.4), for the seasons 2019/2020 and 2020/2021, with an option for a further 2 seasons. Vis anskaffelsen »
The Norwegian Institute of Public Health is holding an open tender contest with the aim of ensuring sufficient deliveries of 4 valent vaccinations against seasonal influenza (ATC code J07B B02) for vaccinating adults in defined risk groups, (see the tender documentation, point 1.4), for the seasons 2019/2020 and 2020/2021, with an option for a further 2 seasons. Vis anskaffelsen »
2017-11-16
Booster vaccine against diphtheria, tetanus, whooping cough and polio to the child vaccination program (DTP-IPV) in... (Folkehelseinstituttet)
The objective of the procurement is to ensure the delivery of booster vaccine against diphtheria, tetanus, whooping cough and polio to the child vaccination program in the 2nd year for the period 2018-2021. Vis anskaffelsen »
The objective of the procurement is to ensure the delivery of booster vaccine against diphtheria, tetanus, whooping cough and polio to the child vaccination program in the 2nd year for the period 2018-2021. Vis anskaffelsen »